Paul Cuddon

Related by string. * P aul . paul . Pauls . Pauling . PAULS . PAUL . Pauler . Paul : PAUL J. WEBER . Jim Thome Paul Konerko . Paul di Resta . Paul Blart Mall Cop . Paul Konerko homered . Ryan Giggs Paul Scholes . EPA PAUL BUCK . By PAUL NEWBERRY . Rand Paul . PAUL Minn. Mikko Koivu . PAUL Minn. Humorist Garrison . Paul Travelers Cos. . Paul Teed » / : Cuddon Cycling Marlborough . Cuddon * *

Related by context. All words. (Click for frequent words.) 64 analyst Nick Batram 64 Nick Batram 63 Andrew Nussey 61 Finncap 60 Sav Neophytou 60 Sam Fazeli 59 Wyn Ellis 59 Andreas Theisen 59 Nick Spoliar 59 Christian Koefoed Nielsen 58 Navid Malik 58 Olav Zilian 58 Youssef Ziai 57 analyst Sanjay Vidyarthi 57 Sebastien Jantet 57 Cormac Leech 57 analyst Jaap Meijer 57 Gbola Amusa 56 analyst Navid Malik 56 Morten Singleton 56 Geoff Allum 56 Jonathan Groocock 56 Nicola Mallard 56 Jonathan Imlah 56 Ambrian Partners 56 Michael Blogg 56 Richard Slape 56 Roman Cizdyn 55 analyst Cory Kasimov 55 Savvas Neophytou 55 Jeffrey Holford 55 Marc Leemans 55 Andrew Gollan 55 Robin Chhabra 54 Yaron Werber 54 Richard Menzies Gow 54 Brock Salier 54 H1 pretax rises 54 Swiss brokerage Helvea 54 analyst Morten Singleton 54 Broker Roundup 54 BROKERWATCH 54 Gerry Hennigan 54 analyst Ross Muken 54 Sebastian Orsi 54 Geoff Meacham 54 Greg Feehely 54 Dominic Valder 53 Karl Heinz Koch 53 Cambridge Antibody 53 David Jeary 53 WestLB Panmure 53 Antoine Leurent 53 Jami Rubin 53 Hugh Guy Lorriman 53 Broker snap 53 Nick Bertolotti 53 analyst Maarten Altena 53 Philip Dorgan 53 Singer Capital Markets 53 Teathers 53 analyst Geoffrey Meacham 53 Broker Cazenove 53 Steve Liechti 52 Evolution Beeson Gregory 52 analyst Wim Hoste 52 Williams de Broe 52 analyst Alexander Peterc 52 Mark Schoenebaum 52 Skyepharma 52 analyst Jim Birchenough 52 Eithne O'Leary 52 Katharine Wynne 52 Williams de Broë 52 Ranjit Kapadia 52 brokerage Helvea 52 Tim Linacre 52 Dolat Capital Market 52 analyst Gert Zonneveld 52 Kevin Lapwood 52 Tilbian 52 BRIEF RESEARCH ALERT Numis 52 Evolutec 52 Arthro Kinetics 52 Ivan Lathouders 52 Gert Zonneveld analyst 52 Broker Panmure Gordon 51 Chris Shibutani 51 Geoffrey Meacham 51 Manus Costello 51 Nigel Parson 51 reiterates FY 51 Trippitt 51 Janardan Menon 51 Isaac Ro 51 stockbroker Seymour Pierce 51 Immunodiagnostic Systems 51 Morning Eyecatchers 51 Bernard Hanssens 51 Oliver Gilvarry 51 Exane BNP 51 Bhavin Shah 51 firmed #.#p [002] 51 BRIEF RESEARCH ALERT 51 Jason Kolbert 51 Karl Heinz Scheunemann 51 Michael Leuchten 51 Akhtar Samad 51 Sara Michelmore 51 Lakis Athanasiou 51 analyst Youssef Ziai 51 Eric Ende 51 Irfan Younus 51 Geoff Porges 51 analyst Jim Reddoch 51 Dolmen Securities 51 Arbuthnot Securities 51 sees FY pretax 51 Jim Reddoch 51 Thomas Nagtegaal 51 Gerald Khoo 51 Joel Sendek 51 Liam Igoe 51 brokerage Numis 51 Jason Kantor 51 Péter Tordai 51 analyst Victor Bareno 51 analyst Bruce Nudell 50 economist Rainer Guntermann 50 Jim Birchenough 50 analyst Jonathan Aschoff 50 Bret Holley 50 broker Panmure Gordon 50 Glenn Reicin 50 Kochnover 50 Schering SHR 50 analyst Leon Esterhuizen 50 Louise Makin 50 Kevin Scotcher 50 Doliveux 50 Mike Trippitt analyst 50 FinnCap 50 Worldspreads 50 Emcure 50 Kuni Chen 50 analyst Dougie Youngson 50 FY pretax rises 50 Angelos Anastasiou 50 Mike Trippitt 50 Job Langbroek 50 Sharewatch 50 Atsushi Seki 50 Damian McNeela 50 Annabel Samimy 50 ImmunoGen IMGN 50 Birgit Kulhoff 50 Pantginis 50 Geoff Ruddell 50 Imran Akram 50 broker Seymour Pierce 50 KBC Peel Hunt 50 analyst Ken Trbovich 50 Roger Cursley strategist 50 finnCap 50 FY# Adj 50 Ricky Goldwasser 49 analyst Gbola Amusa 49 Stig Nymann 49 Glance STOCKS NEWS EUROPE 49 Deltex Medical 49 Gary Nachman 49 analyst Tore Svanberg 49 Panagiotis Spiliopoulos 49 Bert Hazlett 49 Martin Deboo 49 Panmure Gordon stockbrokers 49 Lukas Daalder 49 Sanjay Vidyarthi 49 Altium Securities 49 Mikir Shah 49 broker Brewin Dolphin 49 Jonathan Hykawy 49 Oncogenex 49 Mark Ebbinghaus 49 Mark Monane 49 Andrew Kasoulis 49 Broker Numis 49 Joseph Pantginis 49 Jonathan Groocock analyst 49 Charles Kernot 49 Surajit Pal 49 Neurosearch 49 analyst Liana Moussatos 49 Avacta 49 Panmure analyst 49 Shiv Kapoor 49 Motivcom 49 Merrion Stockbrokers 49 Matthew McEachran analyst 49 JJ Traynor 49 analyst Randall Stanicky 49 Hans Joachim Lohrisch 49 Barrie Cornes analyst 49 Dr. Jim Birchenough 49 analyst Glenn Novarro 49 James Grzinic 49 Gudme Raaschou 49 Chris Umiastowski 49 Bridgewell Securities 49 broker Numis 49 Rachael Waring 49 Tejinder Randhawa 49 Hans Slob 49 Gidley Kitchin 49 BRIEF RESEARCH ALERT Panmure 49 analyst Charles Kernot 48 biomarkers predictive 48 Merrion Capital 48 Helvea SA 48 Redburn Partners 48 Nick Bubb retail 48 Joshua Schimmer 48 Ramona Tipnis 48 Mirabaud Securities 48 Johan Eliason 48 Ken Cacciatore 48 Hanson Westhouse 48 analyst Raj Denhoy 48 Close Bros 48 Broker Investec 48 Roopesh Patel 48 Denhoy 48 Molowa 48 Julian Heslop 48 Andrew Vaino 48 Abcam 48 Vincent Mutel CEO 48 Bryan Garnier 48 Blue Oar Securities 48 Kenji Masuzoe 48 Simon Lowth 48 undemanding valuation 48 positive newsflow 48 Yule Catto 48 Ronny Gal 48 Clive Forestier Walker 48 Tao Levy 48 analyst Bruce Cranna 48 Helvea 48 Numis 48 analyst Mario Mendonca 48 analyst Mark Schoenebaum 48 strategist Mike Lenhoff 48 George Grofik 48 Astaire Securities 48 Physiomics 48 Panmure Gordon downgraded 48 analyst Maged Shenouda 48 Alastair Benbow 48 Wolfgang Renner 48 broker Numis Securities 48 analyst Andrew Goodsall 48 Stanley stockbrokers 48 Schoenebaum 48 Bruce Cranna 48 analyst Jami Rubin 48 Degroof 48 Edward Tenthoff 48 analyst Didier Scemama 48 analyst Martin Deboo 48 Seymour Pierce reiterates 48 Erkki Vesola 48 Monane 48 Mark Photiades 48 analyst Yaron Werber 47 Barrie Cornes 47 H1 pretax 47 Tesofensine 47 Raghu Hariharan 47 Asa Bridle 47 Darren Lehrich 47 Eric Coldwell 47 Bridgewell 47 Geoffrey Porges 47 Simon Toyne 47 Phil Codling 47 Martin Mabbutt 47 Bruce Nudell 47 GBP#.#M [001] 47 Shire PLC SHP.LN 47 Aspect Huntley 47 Jon Lecroy 47 Quantica 47 Seymour Pierce reiterated 47 broker KBC Peel 47 James Manuso 47 Matthew McEachran 47 Landsbanki Kepler 47 LSE IMT 47 Roland Haefeli 47 Cannacord 47 Exane 47 Claude Camire 47 Marchel Alexandrovich 47 Broker Seymour Pierce 47 Cannacord Adams 47 Randall Stanicky 47 reinitiated coverage 47 Altium Securities analyst 47 Tenthoff 47 Liberum 47 analyst Mark Monane 47 Michael Shillaker 47 analyst Tony Shiret 47 Lonza LONN.VX 47 Arden Partners 47 Lars Ekman 47 Vinay Bedi 47 Tesco TSCO.LN 47 Raj Denhoy 47 Simon Moroney 47 Batram 47 analyst Angelos Anastasiou 47 Ton Gietman 47 John Buonaccorsi 47 Panmure Gordon analyst 47 H1 pretax falls 47 Tony Shiret analyst 47 Richard Withagen 47 Westhouse Securities 47 told Outsourcing Pharma.com 47 Cory Kasimov 47 Matt Emmens 47 Claude Zehnder 47 Luuk van Beek 46 Zeneus Holdings 46 Irene Himona 46 analyst Albert Savastano 46 analyst Simon Toyne 46 Carr Sheppards 46 Landsbanki reiterating 46 Sanganeria 46 Simeonidis 46 analyst Greg Feehely 46 Provalis 46 PaperlinX PPX 46 Nicolas Ceron 46 Croda International 46 analyst Geoffrey Porges 46 #p/share [001] 46 Hikma Pharma 46 analyst Chad Friess 46 David Amsellem 46 Alexandra Hauber 46 Matthew Emmens 46 Tubby Goodwin 46 Anne Critchlow 46 Hargeaves 46 AstraZeneca AZN.ISE 46 STOCKS NEWS 46 Enskilda Securities 46 Analyst Richard Withagen 46 equalweight rating 46 Panmure Gordon reiterated 46 Louis Miscioscia 46 De Broe 46 Harit Shah 46 materially undervalues 46 Nominated Advisor 46 Kalpesh Kapadia 46 NeutraHealth 46 analyst Lakis Athanasiou 46 SPECULATIVE BUY 46 Mike Lenhoff strategist 46 analyst Tero Weckroth 46 Deepak Pareek 46 Stacy Rasgon 46 sees FY opg 46 CML Microsystems 46 PV Crystalox 46 Dhulsini de Zoysa 46 Glenn Novarro 46 Bank Degroof analyst 46 FY pretax profit 46 Broker KBC Peel 46 Omega Diagnostics 46 analyst Liam Igoe 46 stockbroker Panmure Gordon 46 analyst Julian Easthope 46 LandSecs 46 Aaron Reames 46 Dominic O'Kane 46 ITV ITV.LN 46 Navdeep Jaikaria 46 Philipp Haessler 46 #-#.# mln [002] 46 Iain Scouller 46 analyst Jeremy Batstone 46 Carl Christensen XPRESSTRADE 46 Brewin Dolphin 46 Virotec International 45 Geoffrey Dicks economist 45 Fabrizio Croce 45 Quynh Pham 45 Rupak Ghose 45 Kian Abouhossein 45 Farooq Hanif 45 Emkay Research 45 Emmanuel Papadakis 45 biggest faller shedding 45 Helvea AG 45 Aveva 45 Bank Degroof 45 Ambrian 45 analyst Amit Bhalla 45 Julian Easthope 45 Cazenove downgraded 45 Chief Executive Hubertus Erlen 45 Lorna Tilbian 45 analyst Amit Hazan 45 Maintains Buy 45 Seymour Pierce upgraded 45 Hargreaves Landsdown 45 JPMorgan Cazenove 45 Origo Sino India 45 Liberum Capital Ltd. 45 £ #.#m PBT 45 Reiterate Outperform rating 45 CAI Cheuvreux 45 Patrik Schwendimann 45 Alex DeGroote 45 Isis Pharma 45 Magnus Mathewson 45 Christows 45 Keijser Capital 45 analyst Hari Sambasivam 45 Maintain Buy 45 Reiterates Hold 45 #-#/# firmer [001] 45 Richard Treagus 45 Alasdair Locke 45 Stefan Schuermann 45 BiolineRX 45 Edward Vandyk 45 Bank Oyens 45 Bonte Friedheim 45 NovoNordisk 45 Q2 opg 45 Mattioli Woods 45 ATH Resources 45 ULJK Securities 45 analyst Robyn Karnauskas 45 broker FinnCap 45 Panmure Gordon 45 Greatfleet 45 Religare Hichens Harrison 45 analyst Grant Saligari 45 caterer Compass Group 45 Moshe Katri 45 Petercam analyst 45 Numis Securities 45 Keay Nakae 45 Fyshe 45 EPT Disclosure BHP Billiton 45 NCB stockbrokers 45 AB Foods 45 Georg Marti 45 firmed #.#p [001] 45 analyst Simos Simeonidis 45 Ken Trbovich 45 Vuk Trifkovic 45 Evolution Securities 45 Jeremy Batstone 45 Hoodless Brennan 45 broker finnCap 45 CE Unterberg 45 brokerage Cheuvreux 45 Cyrus Mewawalla 45 Carla Antunes da Silva 45 broker Teather 45 #p/share [002] 45 RESEARCH ALERT Goldman 45 Arjan van Veen 45 Winterflood Securities 44 Silviu Itescu 44 Novartis Gilenia 44 Jaap Meijer 44 Andrew Lobbenberg 44 Moussatos 44 Royalblue 44 SPECULATIVE BUY recommendation 44 Sven Borho 44 Wise Speke 44 Robin Bienenstock 44 Seshadri Sen 44 Maintains outperform 44 Oriel Securities Ltd. 44 analyst Takeo Miyamoto 44 analyst Konrad Becker 44 H1 pretax profit 44 Ulrich Dauer CEO 44 Leerink 44 Goodbody stockbrokers 44 Telegraph Questor 44 SNS Securities 44 Andrew Fitchie 44 Eliseo Salinas 44 analyst Sapna Srivastava 44 Rajiv Gulati 44 OneClickHR 44 Christopher Hogbin 44 Nicholas Landekic 44 LODH 44 RESEARCH ALERT 44 Daniel Fannon 44 Landesbank Rheinland Pfalz 44 independent brokerage Helvea 44 Sumit Malhotra 44 Shuji Shirota economist 44 Andreas Venditti 44 opg margin 44 GlaxoSmithKline PLC GSK.LN 44 Brics PCG 44 Ovum Holway 44 analyst Alex Gauna 44 Mmo2 44 Steve Meintjes 44 Dirk Hoffmann Becking 44 Per Olof Wallström 44 #.#pa share [002] 44 marketperformer 44 Trevor Polischuk 44 GBP2bn 44 Assumes Coverage 44 Matchtech 44 P Lilladher 44 Azad Zangana 44 Martin Nicklasson CEO 44 broker Killik 44 Henderson Crosthwaite 44 Ronan O'Caoimh CEO 44 Publisher Reed Elsevier 44 Geoff Dicks 44 BioWisdom 44 Cazenove 44 Nasdaq PRXL 44 JP Morgan Cazenove 44 fullyear 44 FY adj pretax 44 Ton van Ooijen 44 analyst Dirk Peeters 44 Limited Nominated Adviser 44 FBD Holdings 44 Pierre Ferragu analyst 44 Oriel Securities analyst 44 Romit Shah 44 Peter Rozenberg 44 Mike Krensavage 44 analyst Harm Meijer 44 analyst Fabrizio Croce 44 Seymour Pierce stockbrokers 44 Prashant Nair 44 reaffirmed Market Perform 44 Charles Kernot mining 44 Wm Morrison Supermarkets 44 Fernand de Boer 44 FY opg 44 humanised antibody designed 44 Statpro 44 Burdett Buckeridge Young 44 Jon LeCroy 44 Reiterates Buy 44 broker Ambrian 44 Nils Machemehl 44 Panmure 44 Inc JEF JEF 44 Elara Capital 44 SG Secs 44 gets USFDA nod 44 Jeffrey Frelick 44 Stanicky 44 Creditsights 44 Roger Longman 44 Investec Securities 44 Cormark Securities 44 Brian Uhlmer 43 Orbimed 43 pre exceptionals 43 reaffirmed Outperform rating 43 Getech 43 WM Morrison 43 Kepler Capital Markets 43 Roger Boissonneault 43 Oxford Catalysts 43 Ortac Resources 43 analyst Lawrence Keusch 43 Liberum Capital 43 Acertec 43 Jean Pierre Lehner 43 Rabo Securities 43 Craig Siegenthaler 43 Shaojing Tong 43 David Molowa 43 Kleinwort Capital 43 Reiterates Buy rating 43 analyst Randy Binner 43 KBC Securities 43 analyst Phillip Nalbone 43 analyst Patrick Walravens 43 Topps Tiles 43 UNiTAB UTB 43 Amir Rozwadowski 43 Ivor Ries 43 Merrill lynch 43 Oriel Securities 43 Safi Bahcall Ph.D. 43 Helvea analyst 43 Greene King GNK.L 43 BNP Exane Paribas 43 Naeem Wahid 43 Ashcourt Rowan 43 Tom Gidley Kitchin 43 ImmunoCellular Therapeutics 43 SThree 43 Suntrust Robinson Humphrey 43 Numis downgraded 43 Alen Buckley 43 Nick Bubb analyst 43 Willem Sels 43 St. Modwen Properties 43 Manoj Ladwa 43 Broker Altium Securities 43 BoA ML 43 Rabo Securities analyst 43 Jason Gurda 43 Krensavage 43 Seymour Pierce downgrades 43 Ross Muken 43 Sushil Finance 43 Rene Locher 43 Roch Doliveux 43 FY pretax 43 Claimar Care Group 43 Join DailyFX 43 British Polythene 43 Sven Borho partner 43 Analyst Toni Sacconaghi 43 BioMedTracker 43 Icap Plc 43 Kemp Dolliver 43 Sarabjit Kour Nangra 43 Antony Broadbent 43 Webis Holdings 43 Bglobal 43 William Plovanic 43 Maintains Overweight 43 Nigel Dally 43 analyst Larry Biegelsen 43 Paul Averback 43 Jefferies Quarterdeck division 43 Equinet 43 economist George Tharenou 43 Conygar Investment Company 43 Vodafone VOD.ETR 43 Charles Pretzlik 43 rerate 43 Aloprim 43 Phil Nalbone 43 Giriraj Daga 43 Erik Suppiger 43 Alnylam Nasdaq ALNY 43 Execution Noble 43 Teather 43 analyst Olaf Kayser 43 Martin Nicklasson 43 Kulbinder Garcha 43 Frater Asset Management 43 Ananda Baruah 43 CE Unterberg Towbin 43 Claire Enders 43 Meredith Adler 43 Blue Oar 43 Bridgewell Securities downgraded 43 Matthew Heimermann 43 analyst George Grofik 43 visiongain 43 Meldex 43 Sucden brokers 43 analyst Mike Trippitt 43 Larry Biegelsen 43 Ambrian Capital 43 Vontobel analyst 43 Cailey Barker 43 analyst Richard Withagen 43 Hawkpoint 43 Hichens Harrison 43 Avior Research 43 Olaf Kayser 43 Dresdner Wasserstein 43 Whittaker Macnaught 43 Jupiters JUP 43 Westhall Capital 43 mmO2 plc 43 Cyan Holdings 43 analyst Nick Bubb 43 Cannacord Genuity 43 Zavoico 43 Sydbank analyst Rune Dahl 43 Robert Spanheimer 42 told BioWorld Today 42 #p/shr 42 Solca 42 Rob Bamforth principal 42 KRChoksey 42 Marco Strittmatter 42 #/#p [005] 42 HwangDBS Vickers 42 Accsys Technologies 42 analyst Mikir Shah 42 BetsForTraders.com 42 Dresdner Kleinwort 42 RBoS 42 Close Brothers Seydler 42 Barclays Capital BarCap 42 SHAW Stockbroking 42 PV Crystalox Solar 42 opg profit 42 LKP Shares 42 Electra Partners 42 Interims 42 Hasit Joshipura 42 John Biccard 42 Hwang DBS 42 stockbrokers Seymour Pierce 42 Bank Vontobel analyst 42 Orbimed Advisors LLC 42 Hargreaves Lansdown stockbrokers 42 SEB Enskilda 42 Michael Kovacocy 42 Rod Bourgeois 42 Keeps Neutral 42 RBS Hoare Govett 42 Broker Numis Securities 42 CM CIC Securities 42 Chris Alliott 42 Healthcare Locums 42 Saftlas 42 Artilium 42 Kirsten Drejer 42 Lombard Odier Darier Hentsch 42 Jelf Group 42 Braemar Shipping Services 42 Goodbody Stockbrokers 42 Sondex 42 Faroe Petroleum 42 Laboratories Rahway NJ 42 Outperformer rating 42 Emer Lang 42 Marcus Padley 42 Novartis Diagnostics 42 Growth Equities 42 BofA ML 42 Computacenter 42 MERIZ 42 Offshore Hydrocarbon 42 Ryan Kneale 42 CSFB Upgrades 42 Elie Darwish 42 JoAnne Feeney 42 Natixis Bleichroeder analyst 42 Joe Pantginis 42 Finola Burke 42 Jonathan Aschoff 42 Jerry Doctrow 42 Sareum Holdings 42 Reiterate Buy 42 Mihael Polymeropoulos 42 Ciaran Callaghan 42 Accumulate rating 42 Todd Bault 42 Bernd Seizinger 42 Maintains Buy rating 42 Empresaria 42 London insurer Amlin 42 analyst Joanne Wuensch 42 Leerink Swan 42 analyst Glenn Reicin 42 AlphaValue 42 Acrux Limited 42 analyst Kemp Dolliver 42 Craig Woolford 42 Bluebay Asset Management 42 Charlemagne Capital 42 Sijmen de Vries 42 JM Finn 42 Rashmi Barbhaiya 42 jeweler Signet 42 Apurva Shah head 42 Khuram Chaudhry 42 Tepnel Life Sciences 42 Davy Stockbrokers 42 analyst Peter Misek 42 analyst Antony Broadbent 42 Merck Finck analyst 42 analyst Mahesh Sanganeria 42 Alastair Riddell 42 Dr. Pim Kon 42 TroVax ® 42 Funtleyder 42 Trevor Mundel 42 Brett Le Mesurier 42 Pierre Flabbee 42 Claudia Lenz 42 anlayst 42 stockbroker Teather & 42 Lapwood 42 Severfield 42 Munich Re MUV2.XE 42 Danske Equities 42 Avingtrans 42 stockbrokers Brewin Dolphin 42 Credit Lyonnais Rouse 42 DrugResearcher.com 42 Ladbrokes eGaming 42 Sector Outperform 42 Healthcare Conf 42 #-#/# pence firmer [002] 42 Goshawk Insurance 42 Westhouse 42 Caterer Compass 42 analyst Seamus Fernandez 42 Persimmon Taylor Wimpey 42 Nextech Venture 42 Dolmen Stockbrokers 42 Research Equities MRE 42 Seymour Pierce analyst 42 Centrica CNA.LN 42 #.#pa share [003] 42 analyst Alexandra Hauber 42 David Pernock 42 Glotel 42 Gets Downgraded 42 Chief Executive Matthew Emmens 42 Canaccord 42 Ibersecurities 42 Sidney Taurel chairman 42 WestLB Ups 42 RBOS 42 told FoodandDrinkEurope.com 42 Netplay TV 42 Knut Woller 42 Sandra McCullagh 42 Natexis 42 Sascha Seegan lead 42 Rowan Dartington 42 Eva Quiroga 42 interdealer broker Tullett Prebon 42 Liisa Bayko 42 Manishi Raychaudhuri 42 JPMorgan Cazenove Ltd. 42 Andrew Goodsall 42 outperformer rating 42 reaffirmed Neutral 42 FTSE# constituent 42 cash generative 42 Harm Meijer 42 Sin Siew 42 Carl Seiden 41 EpiTherapeutics 41 Jack Chemello 41 Maraganore 41 Anders Ekblom 41 Ian Somaiya 41 Northacre 41 Questor 41 Stephen Evans Freke 41 Equinet analyst 41 #.#X FY# [001] 41 analyst Andrew Fitchie 41 analyst Charles Boorady 41 analyst Mathias Bueeler 41 marketperform 41 BUY recommendation 41 insurer Amlin 41 KG Ananthakrishnan 41 Somesh Sharma 41 UBS Warburg retains 41 Angel Broking Ltd. 41 Alkane Energy 41 Stewart Tullet 41 Lloyds TSB LYG 41 Vislink 41 analyst Robert Cihra 41 Emkay 41 Venkat Jasti 41 SciSys 41 FuturaGene 41 Actelion Pharmaceuticals Ltd. 41 consultancy CCS Insight 41 SHK Research 41 stockbroker Hargreaves Lansdown 41 analyst Ton Gietman 41 analyst Syd Vianello 41 GSJB Were 41 analyst Silke Stegemann 41 DrKW 41 GBP#.#M [003] 41 Masstock 41 Joshua Raskin 41 CCZ Equities 41 Steven Harr 41 Seymour Pierce 41 Company Report companiesandmarkets.com 41 Outperformer 41 Des Kilalea 41 Dowgate 41 Religare Wellness 41 economist Dermot O'Leary 41 James Kumpel 41 Imara SP Reid 41 Genuity Capital 41 HaiKe Chemical Group 41 Dr. LaMattina 41 Daniel Vasella Chairman 41 Biomarin 41 ANALYST TAKE Jefferies 41 stockbroker Brewin Dolphin 41 analyst Louis Miscioscia 41 Altium Securities upgraded 41 Huveaux 41 analyst Raghu Hariharan 41 EarlyBirdCapital 41 analyst Per Lekander 41 Manuel Oliveri 41 Shiret 41 Landsbanki Kepler analyst 41 Hartest Holdings 41 Maintains Outperform 41 Seymour Pierce downgraded 41 Aderis 41 Dmitry Silversteyn 41 APCIMS 41 Oliver Hemsley 41 Petercam 41 Alembic HC Securities 41 GBP #mln 41 Hg Capital 41 Evli Bank 41 Girish Tyagi 41 Julien Roch 41 Ixis Securities 41 Barry Sine 41 Morrison Supermarkets 41 Nick Selvaratnam 41 Neurobiological Technologies 41 Talvivaara Mining 41 Remi Barbier 41 Deutsche Boerse DB1.XE 41 analyst Robert Drbul 41 Philippe Archinard 41 JP Garnier 41 Atif Malik 41 Huntsworth 41 Tersus Energy 41 MolMed 41 BT.A 41 Isis Asset Management 41 CM CIC 41 Mepha AG 41 Aventis Pharma Ltd 41 John Clemmow 41 BAS ML 41 MFI Furniture 41 Jeremy Sussman 41 Ranbaxy Cipla 41 William Tanona 41 IndiaInfoline 41 Prabhudas Lilladher Pvt 41 Marketperform 41 Kyran McLaughlin 41 Ed Woolfitt 41 3/share 41 Ashutosh Datar 41 Numis analyst 41 Andreas Rummelt 41 housebuilder Bovis Homes 41 Brewin Dolphin Securities 41 Stanley Sutherlands 41 Berkelder 41 Mislav Matejka 41 Theodoor Gilissen 41 Oswald Clint 41 #.#p [008] 41 Peer Schatz 41 Satish Betadpur 41 Patrice Milos 41 Cantor Fitzgerald reiterates 41 Kash Rangan 41 Scott Mushkin

Back to home page